2 Feb 2018 07:00
NMC Health plc
Appointment of Citi Group as Joint Corporate Broker
London, 2 February 2018: NMC Health plc (LSE: NMC), the leading United Arab Emirates private healthcare operator with international services across 13 countries announces the appointment of Citi Group as Joint Corporate Broker working alongside HSBC and J.P. Morgan.
Contacts
Investors |
|
NMC |
|
Simon Watkins, Group Company Secretary | +44 (0)20 3205 7313 |
|
|
Media: | |
FTI Consulting, London | |
Brett Pollard | +44 (0)20 3727 1000 |
FTI Consulting, Gulf | |
Shane Dolan | +971 (0)4 437 2100 |
About NMC Health
The NMC group (the "Group") is the leading United Arab Emirates private healthcare operator with an international network of hospitals. The Group currently operates or manages over 130 assets across 13 countries. NMC is also ranked as one of the top 3 in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, the company now has over 35% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the company has introduced long-term and multi-specialty care services. The enlarged Group received almost 4.3 million patients in 2016. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1.2 billion for the year ended 31 December 2016.
In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.